Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Adalimumab Biosimilar Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the global Adalimumab Biosimilar market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Adalimumab Biosimilar in these regions, from 2014 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Adalimumab Biosimilar market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tablet
Oral Solution
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Adalimumab Biosimilar for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Adalimumab Biosimilar Market Research Report 2019
1 Adalimumab Biosimilar Market Overview
1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Adalimumab Biosimilar Segment by Type (Product Category)
1.2.1 Global Adalimumab Biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2014-2024)
1.2.2 Global Adalimumab Biosimilar Production Market Share by Type (Product Category) in 2018
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Global Adalimumab Biosimilar Segment by Application
1.3.1 Adalimumab Biosimilar Consumption (Sales) Comparison by Application (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Market by Region (2014-2024)
1.4.1 Global Adalimumab Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2014-2024)
1.4.2 North America Status and Prospect (2014-2024)
1.4.3 Europe Status and Prospect (2014-2024)
1.4.4 China Status and Prospect (2014-2024)
1.4.5 Japan Status and Prospect (2014-2024)
1.4.6 Southeast Asia Status and Prospect (2014-2024)
1.4.7 India Status and Prospect (2014-2024)
1.5 Global Market Size (Value) of Adalimumab Biosimilar (2014-2024)
1.5.1 Global Adalimumab Biosimilar Revenue Status and Outlook (2014-2024)
1.5.2 Global Adalimumab Biosimilar Capacity, Production Status and Outlook (2014-2024)

2 Global Adalimumab Biosimilar Market Competition by Manufacturers
2.1 Global Adalimumab Biosimilar Capacity, Production and Share by Manufacturers (2014-2019)
2.1.1 Global Adalimumab Biosimilar Capacity and Share by Manufacturers (2014-2019)
2.1.2 Global Adalimumab Biosimilar Production and Share by Manufacturers (2014-2019)
2.2 Global Adalimumab Biosimilar Revenue and Share by Manufacturers (2014-2019)
2.3 Global Adalimumab Biosimilar Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Adalimumab Biosimilar Market Competitive Situation and Trends
2.5.1 Adalimumab Biosimilar Market Concentration Rate
2.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Adalimumab Biosimilar Capacity, Production, Revenue (Value) by Region (2014-2019)
3.1 Global Adalimumab Biosimilar Capacity and Market Share by Region (2014-2019)
3.2 Global Adalimumab Biosimilar Production and Market Share by Region (2014-2019)
3.3 Global Adalimumab Biosimilar Revenue (Value) and Market Share by Region (2014-2019)
3.4 Global Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.5 North America Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.6 Europe Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.7 China Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.8 Japan Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.9 Southeast Asia Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.10 India Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Adalimumab Biosimilar Supply (Production), Consumption, Export, Import by Region (2014-2019)
4.1 Global Adalimumab Biosimilar Consumption by Region (2014-2019)
4.2 North America Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)
4.3 Europe Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)
4.4 China Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)
4.5 Japan Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)
4.6 Southeast Asia Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)
4.7 India Adalimumab Biosimilar Production, Consumption, Export, Import (2014-2019)

5 Global Adalimumab Biosimilar Production, Revenue (Value), Price Trend by Type
5.1 Global Adalimumab Biosimilar Production and Market Share by Type (2014-2019)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2014-2019)
5.3 Global Adalimumab Biosimilar Price by Type (2014-2019)
5.4 Global Adalimumab Biosimilar Production Growth by Type (2014-2019)

6 Global Adalimumab Biosimilar Market Analysis by Application
6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2014-2019)
6.2 Global Adalimumab Biosimilar Consumption Growth Rate by Application (2014-2019)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Adalimumab Biosimilar Manufacturers Profiles/Analysis
7.1 AET BioTech
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Adalimumab Biosimilar Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AET BioTech Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business/Business Overview
7.2 Amgen
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Adalimumab Biosimilar Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Amgen Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Adalimumab Biosimilar Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Boehringer Ingelheim Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business/Business Overview
7.4 Coherus Biosciences
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Adalimumab Biosimilar Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Coherus Biosciences Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business/Business Overview
7.5 Fujifilm Kyowa Kirin Biologics
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Adalimumab Biosimilar Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business/Business Overview
7.6 LG Life Sciences/Mochida Pharmaceutical
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Adalimumab Biosimilar Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business/Business Overview
7.7 Momenta Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Adalimumab Biosimilar Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business/Business Overview
7.8 Oncobiologics
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Adalimumab Biosimilar Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Oncobiologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business/Business Overview
7.9 Pfizer
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Adalimumab Biosimilar Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pfizer Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business/Business Overview
7.10 Samsung Bioepsis
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Adalimumab Biosimilar Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Samsung Bioepsis Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business/Business Overview
7.11 Sandoz
7.12 Zydus Cadila

8 Adalimumab Biosimilar Manufacturing Cost Analysis
8.1 Adalimumab Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Adalimumab Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Adalimumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Adalimumab Biosimilar Market Forecast (2019-2024)
12.1 Global Adalimumab Biosimilar Capacity, Production, Revenue Forecast (2019-2024)
12.1.1 Global Adalimumab Biosimilar Capacity, Production and Growth Rate Forecast (2019-2024)
12.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2019-2024)
12.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2019-2024)
12.2 Global Adalimumab Biosimilar Production, Consumption , Import and Export Forecast by Region (2019-2024)
12.2.1 North America Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.2 Europe Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.3 China Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.4 Japan Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.5 Southeast Asia Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.6 India Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.3 Global Adalimumab Biosimilar Production, Revenue and Price Forecast by Type (2019-2024)
12.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2019-2024)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us